A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 1,413 shares of LLY stock, worth $1.05 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
1,413
Previous 1,247 13.31%
Holding current value
$1.05 Million
Previous $1.13 Million 10.81%
% of portfolio
0.35%
Previous 0.33%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $128,175 - $159,363
166 Added 13.31%
1,413 $1.25 Million
Q2 2024

Aug 15, 2024

BUY
$724.87 - $909.04 $262,402 - $329,072
362 Added 40.9%
1,247 $1.13 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $294,915 - $394,555
498 Added 128.68%
885 $688,000
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $44,115 - $52,006
84 Added 27.72%
387 $225,000
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $26,082 - $35,958
60 Added 24.69%
303 $162,000
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $5,261 - $7,034
15 Added 6.58%
243 $113,000
Q1 2023

Jun 20, 2023

BUY
$310.63 - $364.82 $23,297 - $27,361
75 Added 49.02%
228 $78,000
Q4 2022

Mar 02, 2023

SELL
$321.55 - $374.67 $643 - $749
-2 Reduced 1.29%
153 $55,000
Q3 2022

Nov 15, 2022

BUY
$296.48 - $337.87 $11,266 - $12,839
38 Added 32.48%
155 $50,000
Q2 2022

Aug 16, 2022

BUY
$278.73 - $327.27 $557 - $654
2 Added 1.74%
117 $38,000
Q1 2022

Jun 17, 2022

BUY
$234.69 - $291.66 $26,989 - $33,540
115 New
115 $33,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.